Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01957748 · ClinicalTrials.gov registry record · NA
CCTG 594: Engagement and Retention in Care for HIV+
A NA study of HIV Positive and Patient Adherence, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
- 3
- Study locations
NCT01957748 is a NA study of HIV Positive and Patient Adherence that has completed, run by University of California, San Diego. The registered enrollment target is 117 participants, below the 636-participant average among 3 other HIV Positive trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT01957748, a NA study of HIV Positive and Patient Adherence, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
- 3
- Study locations
Study Summary
CCTG 594 is a controlled, unblinded, two-arm, randomized (1:1) clinical trial to evaluate the effectiveness of a clinic-based HIV ALERT specialist on improving endpoints of retention in care and maintenance of ART as compared to the current standard of care (SoC) in HIV primary care clinics.
Conditions Studied
Interventions
- BEHAVIORAL SoC + ALERT Intervention
Study Locations (3)
California
- University Southern California - Los Angeles
- University of California, San Diego - San Diego
- Harbor-UCLA Medical Center - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2013-10-08 |
| Est. Completion | 2020-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01957748
The ClinicalTrials.gov registry entry for NCT01957748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 636-participant average among 3 other HIV Positive trials with a reported enrollment target (82% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Positive appearing as the primary indexed condition, and to 1 intervention - of which SoC + ALERT Intervention is the first listed.
NCT01957748 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01957748 about?
NCT01957748 is a clinical study titled "CCTG 594: Engagement and Retention in Care for HIV+". CCTG 594 is a controlled, unblinded, two-arm, randomized (1:1) clinical trial to evaluate the effectiveness of a clinic-based HIV ALERT specialist on improving endpoints of retention in care and maintenance of ART as compared to the current standard of care (SoC) in HIV primary care clinics.
What is the current status of trial NCT01957748?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2013-10-08. Estimated completion is 2020-11-24.
What conditions does trial NCT01957748 study?
This clinical trial studies the following conditions: HIV Positive, Patient Adherence.
What interventions are being tested in trial NCT01957748?
The interventions under investigation include: SoC + ALERT Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01957748?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01957748 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Positive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.